Sézary syndrome, T-Helper 2 cytokines and accessory factor-1 (AF-1)

Leukemia and Lymphoma

Volumn 28, Issue 5-6, 1998, Pages 515-522

  Dummer, Reinhard ^a   Geertsen, Ralf ^b   Ludwig, Elisabeth ^b   Niederer, Eva ^a   Burg, Günter ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Accessory factor 1; Cutaneous t cell lymphomas (ctcl); Ifn receptor chain; IL 10, IL 5; Mycosis fungoides; S zary syndrome; T helper 2

Indexed keywords

CD7 ANTIGEN; CYTOKINE; DENILEUKIN DIFTITOX; GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 5; MITOGENIC AGENT; GAMMA INTERFERON; IFNGR2 PROTEIN, HUMAN; INTERFERON RECEPTOR;

BLOOD; CELL PROLIFERATION; DELAYED HYPERSENSITIVITY; EOSINOPHILIA; HELPER CELL; HUMAN; IMMUNOPHENOTYPING; LYMPH NODE; MEMORY CELL; MONONUCLEAR CELL; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; REVIEW; SEZARY SYNDROME; SKIN; SKIN LYMPHOMA; IMMUNOLOGY; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN TUMOR; TH2 CELL;

HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-5; MALE; RECEPTORS, INTERFERON; SEZARY SYNDROME; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TH2 CELLS;

EID: 0031595574     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058359     Document Type: Article

References (45)

1. Dummer, R., Michie, S., Kell, D., Could, J., Haeffner, A., Smoller, B., Warnke, R. and Wood, G. (1995). Expression of BCL-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates. 7 Cut Pathol,22, 11-17
2. Burg, G. and Braun-Falco, O. (I983). Cutaneous lymphomas, pseudolymphomas and related disorders (Springer-Verlag, Berlin Heidelberg New York Tokyo).
3. Burg, G., Dummer, R. and Kerl, H. (1994). Classification of cutaneous lymphomas. Denn Clinics, 12, 213-217.
4. Sterry, W. and Mielke, V. (1989). CD4+ cutaneous T-cell lymphomas show the phenotype of helper/inducer T-cells (CD45RA-, CDw29). J Invest Dennatol, 93,413-416.
5. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., deWolf-Peeters, C., Falini, B., Gatter, K., Grogan, K., Isaacson, P., Knowles, D., Mason, D., MüllerHermelink, H.-K., Pileri, S., Piris, M., Ralfkiaer, E. and Warnke, R. (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 84, 1361-1392.
6. Willemze, R., van Vloten, W. A., Hermans, J., Damsteeg, M. J. and Meijer, C. J. (1983). Diagnostic criteria in Sezary's syndrome: a multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma. J Invest Dennatol, 81, 392-397.
7. Rappaport, H. and Thomas, L. B. (1974). Mycosis fungiodes: the pathology of extracutaneous involvement. Cancer, 34, 1198-1229.
8. Wood, G. S. (1992). Benign and malignant cutaneous lymphoproliferative disorders including Mycosis fungoides. In: Neoplastic hematology D. M. Knowles (ed.), pp. 917-952 (Williams & Wilkins, Baltimore).
9. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. and Coffman, R. L. (1986). Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol, 136,2348-2357.
10. Mosmann, T. R. and Moore, K. W. (1991). The role of 1L-10 in crossregulation of TH1 and TH2 responses. Immunol Today, 12, A49-A53.
11. Romagnani, S. (1991). Human TH1 and TH2 subsets: doubt no more. Immunol Today, 12, 256-257.
12. Mosmann, T. R. and Sad, S. (1996). The expanding universe of T-cell subsets-THl, TH2 and more. Immunology Today, 17, 138-146.
13. Nickoloff, B. J., Griffiths, C. E. M.. Baadsgaard, O., Voorhees, J. J., Hanson, C. A. and Cooper, K. D. (1989). Markedly diminished epidermal keratinocyte expression of intercellular adhesion molecule-1 (ICAM-1) in Sezary Syndrome. JAMA, 261, 2217-2221.
14. Vowels, B., Cassin, M., Vondcrheid, E. and Rook, A. (1992). Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermalol, 99,90-94.
15. Dummer, R., Kohl, O., Gillisson, J., Kägi, M. and Burg, G. (1993). Peripheral blood mononuclear cells in non-Ieukemic cutaneous T-cell lymphoma patients: reduced proliferation and preferential secretion of a T-helper 2 like cytokine pattern on stimulation. Arch Dermalol, 129,433-436.
16. Saed, G., Fivenson, D. P., Naidu, Y. and Nickoloff, B. J. (1994). Mycosis fungoides exhibits a Thl-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2type profile. J Invest Dennatol, 103,29-33.
17. Vowels, B. R., Lessin, S. R.,Cassin, M.,Jaworsky,C, Benoît, B., Wolfe, J. T. and Rook, A. H. (1994). Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dennatol, 103,669-673.
18. Asadullah, K., Docke, W.-D., Haeussler, A., Sterry, W. and Volk, H.-D. (1996). Progression of Mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 (IL-10) mRNA. J Invest Dennatol, 107, 833-837.
19. Saed, G., Fivenson, D. and Nickoloff, B. (1995). Th2 cytokine profile in cutaneous T-cell lymphoma- Reply. J Invest Denn, 105, 856.
20. Lessin, S., Vowels, B. and Rook, A. (1995). Th2 cytokine profile in cutaneous T-cell lymphoma. J Invest Denn, 105, 855.
21. Wood, G. S., Haeffner, A. C., Dummer, R. and Crooks, C. (1994). Molecular biology techniques for the diagnosis of CTCL. Denn Clinics, 12, 231-241.
22. Dunn, D. A., Gadenne, A. S., Simlia, S., Lemer, E. A., Bigby, M. and Bleicher, P. A. (1993). T-cell receptor V beta expression in normal human skin. Proc Nail Acad Sei USA, 90, 1267-1271.
23. Gilks, C. B., Ho, V. C., Gascoyne, R. D. and Ellison, D. J. (1992). T-cell receptor variable region gene expression in cutaneous T-cell lymphomas. J Ciitan Patliol, 19, 21-26.
24. O'Grady, J., Krajewski, A. S. and Ramage, E. F. (1990). Demonstration of clonality in T-cell lymphoma using an anti-T-cell receptor variable region antibody panel. Histopathology, 17,553-556.
25. Potoczna, N., Boencke, W.-H., Nestle, F. O., Küenzlen, C., Sterry, W., Burg, G. and Dummer, R. (1996). T-cell receptor beta variable region usage in cutaneous T-cell lymphomas in comparison to normal and eczematous skin. J Cut Pathol, 23, 298-305.
26. Vonderheid, E. C., Bigler, R. D., Greenberg, A. S., Neukum, S. J. and Micaily, B. (1994). Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome. Use of dual marker labeling to monitor therapeutic response. Am J Clin Oncol, 17,255-263.
27. Dummer, R., Heald, P. W., Nestle, F. O., Ludwig, E., Laine, E., Hemmi, S. and Burg, G. (1996). Sézary Syndrome's T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon gamma receptor beta chain). Blood, 88, 1383-1389.
28. Yagi, H., Tokura, Y., Furukawa, F. and Takigawa, M. (1996). Cd7-Positive Sezary Syndrome With a Thl Cytokine Profile. JAm Acad Denn, 34,368-374.
29. Peris, K., Niedermeyer, H., Cerroni, L., Radaskiewicz, T., Chimenti, S. and Hotter, H. (1994). Detection of Epstein-Barr virus genome in primary cutaneous T and B cell lymphomas and pseudolymphomas. Arch Derm Res, 286, 364-368.
30. Hsu, D. H., de Waal Malefyt, R., Fiorentino, D. F., Dang, M. N., Vieira, P., de Vries, J., Spits, H., Mosmann, T. R. and Moore, K. W. (1990). Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science, 250, 830-832.
31. Vieira, P., de Waal-Malefyt, R., Dang,.M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., de Vries, J. E., Roncarolo, M. G., Mosmann, T. R. and Moore, K. W. (1991). Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. ProcNatlAcadSei USA, 88, 1172-1176.
32. Romagnani, S. (1992). Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. IntArch Allergy Immunol, 98,279-285.
33. de Vries, J. E. (1995). Immunosuppressive and anti-inflammatory properties of interleukin 10. Annals of Medicine, 27, 537-541.
34. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P. and Mosmann, T. R. ( 1996). Interleukin-10. Annual Review of Immunology 1993;11:165-90,135, 572-575.
35. Dummer, R., Laine, E., Döbbeling, U., Burg, G. and Nestle, F. (1995). T-cell relevant cytokines during extracorporeal photopheresis (ECP) in Sézary syndrome, detetcted by a newly developped PCR-ELISA technique. J Invest Dennatol, 104, 653 (abstract).
36. Soh, J., Donnelly, R. J., Kotenko, S., Mariano, T. M., Cook, J. R., Wang, N., Emanuel, S., Schwartz, B., Miki, T. and Pestka, S. (1994). Identification and sequence of an accessory factor required for activation of the human Interferon gamma receptor. Cell, 76,793-802.
37. Hemmi, S., Bohni, R., Stark, G., Di Marco, F. and Aguet, M. (1994). A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells. Cell, 76, 803-810.
38. Marsters, S. A., Pennica, D., Bach, E., Schreiber, R. D. and Ashkenazi, A. (1995). Interferon gamma signals via a highaffinity multisubunit receptor complex that contains two types of polypeptide chain. Proc Nail Acad Sei USA, 92, 5401-5405.
39. Pernis,A.,Gupta,S.,Gollob,K.J.,Garfein,E.,Coffman,R.L., Schindler, C. and Rothman, P. (1995). Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in Till cells. Science, 269, 245-247.
40. Bach, E., Szabo, S., Dighe, A., Ashkenazi, A., Aguet, M., Murphy, K. and Schreiber, R. (1995). Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T-helper subsets. Science, 270, 1215-1218.
41. Kaye, F. J., Bunn, P. J., Steinberg, S. M., Stocker, J. L., Ihde, D. C., Fischmann, A. B., Glatstein, E. J., Schlechter, G. P., Phelps, R. M., Foss, F. M., Parlette, H., Anderson, M. and Sausville, E. (1989). A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Aled, 321, 1784-1790.
42. Dummer, R., Häffner, A. C., Hess, M. and Burg, G. (1996). A rational approach to the therapy of cutaneous T-cell lymphomas. Onkologie, 19, 226-230.
43. Brunda, M. J. (1994). Interleukin-12. J Leukoc Dial, 55, 280-288.
44. Rook, A. H., Kubin, M., Cassin, M., Vonderheid, E. C., Vowels, B. R., Wolfe, J. T., Wolf, S. F., Singh, A., Trinchieri, G. and Lessin, S. R. (1995). IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Imnntnol, 154, 1491-1498.
45. Foss, F. M., Borkowski, T. A., Gilliom, M., Steiler, S. M., Jaffe, E. S., Figg, W. D., Tompkins, A., Bastian, A., Nylen, P., Woodworth, T., et al. (1994). Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interIeukin-2 receptor expression in a phase II study. Blood, 84, 1765-1774.